Prothena Corp PLC (PRTA)

Add to Watchlists

Create an Alert

Quickflows

10.35 -1.16 -10.08% NASDAQ Apr 3, 20:00 Delayed 2m USD

Prothena News

Wire

Headline

Time (ET)
Globe Newswire

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04/03 16:05
Globe Newswire

Baseline Data from Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson’s Disease to be Presented at AAT-AD/PD

03/31 16:05
Yahoo

Prothena (PRTA) Down 24.8% Since Last Earnings Report: Can It Rebound?

03/13 11:30
Globe Newswire

Prothena Announces Appointment of Brandon Smith as Chief Business Officer

03/03 16:05
Yahoo

Edited Transcript of PRTA earnings conference call or presentation 12-Feb-20 9:30pm GMT

02/17 18:31
Yahoo

Prothena (PRTA) Q4 Loss Narrower Than Expected, Revenues Beat

02/13 10:45
MT Newswires

Prothena Q4 Results Top Street Estimates

02/13 05:05
Yahoo

Prothena (PRTA) Reports Q4 Loss, Tops Revenue Estimates

02/12 17:35
SA Breaking News

Prothena EPS beats by $0.06, beats on revenue

02/12 16:06
Globe Newswire

Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

02/12 16:05
Yahoo

Prothena Corp. Plc to Host Earnings Call

02/12 14:30
Yahoo

Prothena to Report Fourth Quarter and Full Year 2019 Financial Results and Host Webcast Conference Call on February 12

02/05 16:05
Yahoo

Imagine Owning Prothena (NASDAQ:PRTA) And Trying To Stomach The 71% Share Price Drop

01/20 11:21
SA Breaking News

NIO, SDRL, CTIC and AGRX among midday movers

12/24 11:17
PR Newswire

Thinking about buying stock in Bank of America, LYFT, Prothena Corporation, Rite Aid, or AT&T?

12/23 09:31
SA Breaking News

RAD, CAMP, ABEO and MRNS in midday movers

12/20 12:38
Globe Newswire

Prothena Announces Appointment of Oleg Nodelman to its Board of Directors

12/05 16:05
SA Breaking News

Prothena up 8% on Evercore upgrade

11/19 11:16
SA Breaking News

Evercore downgrades bluebird bio and Clovis in premarket analyst action

11/19 08:12
MT Newswires

--Analyst Actions: Evercore ISI Upgrades Prothena to Outperform From In-Line; Price Target is $14

11/19 08:02

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.